Read More 8 minute read Penny Stocks CN.ORTH: New Blood on The Board By Zacks Small Cap Research Today, 1:24 PM By John Vandermosten, CFA CNSX:ORTH.CN | OTC:ORTIF CSE:ORTH
Read More 8 minute read Uncategorized RKV.V: Picking Up where PARPi Left Off By Zacks Small Cap Research Today, 1:24 PM By John Vandermosten, CFA TSX:RKV.V TSX:RKV
Read More 6 minute read Penny Stocks TGMGF: DFS on Beta, Frankfort & CDM mines expected in 1Q 2022; Completed AUD$7.7 million capital raise (debt & equity) By Zacks Small Cap Research Today, 1:24 PM By Steven Ralston, CFA OTC:TGMGF | ASX:TGM READ THE FULL TGMGF RESEARCH REPORT TGMGF
Read More 5 minute read Penny Stocks ATE.TO: Pivoting to Acute Pain Relief for Otenaproxesul… By Zacks Small Cap Research Today, 1:24 PM By David Bautz, PhD OTC:ATBPF | TSX:ATE.TO READ THE FULL ATE.TO RESEARCH REPORT ATBPF
Read More 3 minute read Penny Stocks SYTA: Despite 2Q21 Sales Miss, We Remain Optimistic about SD7 New Handset Launch for Mission Critical By Zacks Small Cap Research Today, 1:24 PM By T. Moore, CFA NASDAQ:SYTA READ THE FULL SYTA RESEARCH REPORT SYTA
Read More 7 minute read Penny Stocks KTRA: FY21 Financial Results By Zacks Small Cap Research Today, 1:24 PM By John Vandermosten, CFA NASDAQ:KTRA READ THE FULL KTRA RESEARCH REPORT KTRA
Read More 3 minute read Small Cap TRC: Obstacle to TRC Pursuing Development Goals Eliminated By Zacks Small Cap Research Today, 1:24 PM By M. Marin NYSE:TRC READ THE FULL TRC RESEARCH REPORT TRC
Read More 4 minute read Penny Stocks CFRX: New Data on Exebacase Shows Rapid Resolution of Symptoms in Phase 2 Trial… By Zacks Small Cap Research Today, 1:24 PM By David Bautz, PhD NASDAQ:CFRX READ THE FULL CFRX RESEARCH REPORT CFRX
Read More 4 minute read Penny Stocks VIVXF: Landmark Deal with AB Vista… By Zacks Small Cap Research Today, 1:24 PM By David Bautz, PhD OTC:VIVXF READ THE FULL VIVXF RESEARCH REPORT VIVXF
Read More 4 minute read Penny Stocks CLSN: Initiating Coverage of Celsion Corporation; Novel DNA-Based Cancer Immunotherapy Technology… By Zacks Small Cap Research Today, 1:24 PM By David Bautz, PhD NASDAQ:CLSN READ THE FULL CLSN RESEARCH REPORT CLSN